Pharmabiz

ICMR invites EOI for undertaking high end collaborative inter disciplinary research

ICMR invites EOI for undertaking high end collaborative inter disciplinary research: Shardul Nautiyal, Mumbai Friday, December 19, 2025, 08:00 Hrs [IST] The Indian Council of Medi ...
Pharmabiz

PDMA urges govt to allow 2 more years to smaller units to comply with revised Schedule M

PDMA urges govt to allow 2 more years to smaller units to comply with revised Schedule M: Gireesh Babu, New Delhi Friday, December 19, 2025, 08:00 Hrs [IST] With less than a fortn ...
Pharmabiz

IPC 2025 to bolster Bengaluru’s global stand as hub for CRAMS and GCCs, fuelled by quality talent

IPC 2025 to bolster Bengaluru’s global stand as hub for CRAMS and GCCs, fuelled by quality talent: Nandita Vijayasimha, Bengaluru Friday, December 19, 2025, 08:00 Hrs [IST] Indi ...
Opinion
PharmabizOpinion

Union govt must fortify regulatory frameworks to strengthen trust in Indian medicines: Dr Jagashetty

Union govt must fortify regulatory frameworks to strengthen trust in Indian medicines: Dr Jagashetty: Nandita Vijayasimha, Bengaluru Friday, December 19, 2025, 08:00 Hrs [IST] The ...
Pharmabiz

APDCA warns drugs inspectors of strict action if they interfere in pharmacy council elections

APDCA warns drugs inspectors of strict action if they interfere in pharmacy council elections: Peethaambaran Kunnathoor, Chennai Friday, December 19, 2025, 08:00 Hrs [IST] The And ...
Pharmabiz

Global summit on traditional medicine culminates today in New Delhi with vision for integrated healthcare

Global summit on traditional medicine culminates today in New Delhi with vision for integrated healthcare: Peethaambaran Kunnathoor, Chennai Friday, December 19, 2025, 08:00 Hrs [ ...
Pharmabiz

Personalis publishes a new study in Clinical Cancer Research to monitor cancer immunotherapy response across solid tumours

Personalis publishes a new study in Clinical Cancer Research to monitor cancer immunotherapy response across solid tumours: Fremont, California Friday, December 19, 2025, 16:00 Hr ...
Pharmabiz

Symeres earns first SBTi approval as part of long-term sustainability journey

Symeres earns first SBTi approval as part of long-term sustainability journey: Nijmegen, Netherlands Friday, December 19, 2025, 18:00 Hrs [IST] Symeres, a leading contract researc ...
Pharmabiz

Takeda’s zasocitinib landmark phase 3 plaque psoriasis data show promise to deliver clear skin in a once-daily pill, catalyzing a new era of treatment

Takeda’s zasocitinib landmark phase 3 plaque psoriasis data show promise to deliver clear skin in a once-daily pill, catalyzing a new era of treatment: Osaka, Japan Friday, Dece ...
Pharmabiz

Gleneagles Hospital Mumbai introduces the Institute of Onco-Science: A unified centre of excellence for cancer care

As India faces an alarming surge in cancer incidence, Gleneagles Hospital, Parel, Mumbai, has unveiled the Institute of Onco-Science, a comprehensive and fully coordinated cancer care centre designed ...
Pharmabiz

Combination of Castle Biosciences’ DecisionDx-UM and PRAME show predicting outcomes in patients with uveal melanoma: Study

Combination of Castle Biosciences’ DecisionDx-UM and PRAME show predicting outcomes in patients with uveal melanoma: Study: Friendswood, Texas Friday, December 19, 2025, 15:00 H ...
Pharmabiz

Astellas Pharma announces positive topline results from phase 3 EV-304 clinical trial of Padcev plus Keytruda

Astellas Pharma announces positive topline results from phase 3 EV-304 clinical trial of Padcev plus Keytruda: Tokyo Friday, December 19, 2025, 10:00 Hrs [IST] Astellas Pharma Inc ...